Good morning ... This Wall Street Journal story about Malaysian party animal Jho Low is just absolutely wild, and a great way to start your day.
Illustration: Sarah Grillo/Axios
If we’re ever going to get the opioid crisis under control, a major emphasis on addiction treatment will have to be part of the solution. Axios’ Caitlin Owens takes a deep dive this morning into how, exactly, the existing treatment system is falling short and what policy changes could help fix it.
What they’re saying: Public health experts focused on three main priorities for improving access to treatment:
Where it stands: Congress’ opioid bills address some of these issues, but not all. And putting some of them into practice, especially wider access to low-cost MAT, will require new federal investments.
Well this was unexpected: In a survey of 600 executives from hospitals and doctors’ practices, 60% said single-payer would have a “positive” effect on the industry’s efforts to lower costs and provider better care.
My colleague Bob Herman flagged the findings from NEJM Catalyst, an offshoot of the New England Journal of Medicine.
The big picture: Price regulation would lower health care costs. But providers historically haven't considered that a good thing.
ICYMI on Friday, a group largely made up of patient and consumer advocates filed a lawsuit challenging the Trump administration's expansion of skimpy, "short-term" insurance policies.
The big picture: Every major piece — and in fact, several minor pieces — of the Trump administration's health care agenda has sparked a lawsuit. That includes:
Why it matters: Not all of these suits will succeed. But they have the potential to slow or stop big parts of the administration's agenda.
This week will likely be dominated by the allegations against Supreme Court nominee Brett Kavanaugh. Here's what else we'll be watching: